Weight Loss Buddy Emphasizes Support After GLP-1 Treatment
As GLP-1 medications reshape approaches to weight management, Weight Loss Buddy is emphasizing the importance of continued support for individuals navigating changes in treatment, including those transitioning off weight loss medications.
Medications such as Ozempic and Wegovy have brought renewed attention to medical weight management. However, questions remain about maintaining progress after treatment ends, managing expectations and accessing reliable information about medication-related concerns.
A 2022 study published in Diabetes, Obesity and Metabolism found that participants who discontinued semaglutide and structured lifestyle intervention regained approximately two-thirds of their previous weight loss over the following year. The findings highlight the challenges of long-term weight management and the importance of individualized treatment planning.
Excerpted from EIN Press Wire
